Position in BIOA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$234,085
+$213,738 QoQ
Shares Held
13,384
+770.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $466,960,504 across 57 Drug Manufacturers - Specialty & Generic names. BIOA ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
235,620 | $139,717,946 | |
| 2 | ZTS |
Zoetis Inc.
|
1,130,742 | $133,665,010 | |
| 3 | VTRS |
Viatris Inc
|
3,966,552 | $53,588,116 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
832,323 | $25,069,568 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
112,442 | $14,813,107 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
662,928 | $13,762,384 | |
| 7 | HLN |
Haleon plc
|
1,329,934 | $13,312,638 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
160,225 | $12,153,065 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $234,085 | 13,384 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $20,347 | 1,538 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,622 | 276 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $46,082 | 11,158 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $32,098 | 8,537 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $55,323 | 9,555 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||